Complete Filing Data
GRI Bio, Inc. reported Stockholders Equity of $6.01 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GRI Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$12.0M | -$8.2M | -$13.0M | -$3.2M | -$9.3M | -$4.8M |
| Research And Development Expense | $6.8M | $3.8M | $3.2M | $242.0K | $5.2M | $3.7M |
| Operating Income Loss | -$12.0M | -$8.2M | -$11.4M | -$2.2M | -$9.3M | -$4.8M |
| Operating Expenses | $12.0M | $8.2M | $11.4M | $2.2M | $9.3M | $4.9M |
| General And Administrative Expense | $5.2M | $4.5M | $8.2M | $2.0M | $4.1M | $1.2M |
| Interest Income Expense Nonoperating Net | $21.0K | $25.0K | -$2.1M | -$653.0K | -$16.0K | -$34.0K |
| Other Nonoperating Income Expense | $0.00 | $250.0K | $0.00 | $61.0K | $0.00 | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $2.0K | -$2.0K | $0.00 | |||
| Comprehensive Income Net Of Tax | -$7.0M | -$9.3M | -$4.8M | |||
| Interest Income Expense Net | ||||||
| Other Nonoperating Income | ||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $100.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.4M | -$2.9M | -$3.0M | -$2.1M | -$2.3M | -$1.9M | -$2.1M | -$6.7M | -$2.2M | -$351.0K | -$295.0K | -$302.0K | -$1.3M | -$2.3M | -$2.6M | -$1.0M | -$1.1M | -$1.2M |
| Research And Development Expense | $1.8M | $1.9M | $1.6M | $1.1M | $877.0K | $933.0K | $1.2M | $880.0K | $116.0K | $63.0K | $59.0K | $1.3M | $215.0K | $1.2M | $1.8M | $733.0K | $808.0K | $883.0K |
| Operating Income Loss | -$3.4M | -$2.9M | -$3.1M | -$2.1M | -$2.3M | -$1.9M | -$2.4M | -$5.9M | -$988.0K | -$186.0K | -$189.0K | -$2.6M | -$1.3M | -$2.3M | -$2.6M | -$1.0M | -$1.1M | -$1.2M |
| Operating Expenses | $3.4M | $2.9M | $3.1M | $2.1M | $2.3M | $1.9M | $2.4M | $5.9M | $988.0K | $186.0K | $189.0K | $2.6M | $1.3M | $2.3M | $2.6M | $1.0M | $1.1M | $1.3M |
| General And Administrative Expense | $1.6M | $1.0M | $1.4M | $1.0M | $1.4M | $962.0K | $1.3M | $5.1M | $872.0K | $123.0K | $130.0K | $1.4M | $1.0M | $1.1M | $830.0K | $300.0K | $327.0K | |
| Interest Income Expense Nonoperating Net | $6.0K | $5.0K | $5.0K | $7.0K | $6.0K | $6.0K | $6.0K | -$934.0K | -$1.2M | -$165.0K | -$106.0K | |||||||
| Other Nonoperating Income Expense | $0.00 | $250.0K | $0.00 | |||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $2.0K | $3.0K | -$4.0K | -$1.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Comprehensive Income Net Of Tax | -$2.4M | -$1.0M | -$1.8M | -$2.6M | -$1.3M | -$2.3M | -$2.6M | -$1.0M | ||||||||||
| Interest Income Expense Net | $16.0K | $2.0K | -$1.0K | -$1.0K | -$4.0K | -$2.0K | -$8.0K | -$12.0K | -$12.0K | -$2.0K | ||||||||
| Other Nonoperating Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $61.0K | $0.00 | $0.00 | ||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.0M | $4.0M | $259.0K | -$1.6M | -$4.8M | -$1.5M | $3.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.2M | $5.0M | $1.8M | $9.0K | $90.0K | $109.0K | $3.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.2M | $3.2M | $1.8M | -$81.0K | $3.6M | -$3.7M | |
| Retained Earnings Accumulated Deficit | -$51.7M | -$39.7M | -$31.5M | -$18.5M | -$21.9M | -$12.6M | |
| Prepaid Expense And Other Assets Current | $363.0K | $587.0K | $1.1M | $303.0K | $619.0K | $565.0K | |
| Liabilities And Stockholders Equity | $8.7M | $5.7M | $3.0M | $383.0K | $8.3M | $955.0K | |
| Liabilities | $2.7M | $1.7M | $2.7M | $2.0M | $2.5M | $2.4M | |
| Cash And Cash Equivalents At Carrying Value | $8.2M | $5.0M | $1.8M | $9.0K | $3.7M | $109.0K | |
| Assets | $8.7M | $5.7M | $3.0M | $383.0K | $8.3M | $955.0K | |
| Accrued Liabilities Current | $750.0K | $691.0K | $1.3M | $36.0K | $1.4M | $847.0K | |
| Accounts Payable Current | $1.8M | $897.0K | $1.4M | $1.3M | $918.0K | $1.2M | |
| Liabilities Current | $2.6M | $1.6M | $2.7M | $2.0M | $2.4M | $2.2M | |
| Common Stock Value Outstanding | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Assets Current | $8.6M | $5.6M | $2.9M | $312.0K | $8.1M | $674.0K | |
| Additional Paid In Capital Common Stock | $57.7M | $43.8M | $31.8M | $16.9M | $27.7M | $11.1M | |
| Change In Fair Value Of Warrant Liability | $0.00 | $3.0K | $182.0K | $0.00 | |||
| Property Plant And Equipment Net | $3.0K | $4.0K | $8.0K | $4.0K | $0.00 | $2.0K | |
| Operating Lease Right Of Use Asset | $71.0K | $120.0K | $14.0K | $67.0K | |||
| Operating Lease Liability Noncurrent | $15.0K | $71.0K | $0.00 | $14.0K | |||
| Operating Lease Liability Current | $56.0K | $48.0K | $14.0K | $57.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $48.0K | $53.0K | $47.0K | ||||
| Debt Discount And Additional Paid In Capital Recognized From Issuance Of Warrants | $0.00 | $532.0K | $601.0K | ||||
| Debt Conversion Converted Instrument Amount1 | $0.00 | $5.3M | $350.0K | $0.00 | |||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $124.0K | ||||
| Finance Lease Right Of Use Asset Amortization | $206.0K | $73.0K | $74.0K | ||||
| Finance Lease Principal Payments | $15.0K | $106.0K | $65.0K | ||||
| Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | $278.0K | $0.00 | $226.0K | $340.0K | |||
| Stock Issued For Repayment Of Notes Payable | $0.00 | $3.3M | $0.00 | ||||
| Net Liabilities Assumed In Connection With Reverse Recapitalization | $0.00 | $3.9M | $0.00 | ||||
| Accretion Amortization Of Discounts And Premiums Investments | -$28.0K | -$32.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.0M | $3.3M | $1.2M | $3.7M | $4.7M | $2.8M | $2.2M | $4.0M | -$3.2M | -$5.7M | -$5.4M | -$5.2M | $8.7M | $9.9M | $12.0M | -$24.0K | $969.0K | $2.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.1M | $5.1M | $3.3M | $4.7M | $6.4M | $4.1M | $3.5M | $4.8M | $460.0K | $104.0K | $9.0K | $2.5M | $5.9M | $10.5M | $13.0M | $924.0K | $2.0M | $3.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.7M | $2.3M | $451.0K | -$1.2M | $12.9M | -$797.0K | ||||||||||||
| Retained Earnings Accumulated Deficit | -$49.0M | -$45.7M | -$42.8M | -$37.8M | -$35.7M | -$33.4M | -$29.5M | -$27.4M | -$31.3M | -$27.3M | -$26.3M | -$24.5M | -$18.8M | -$17.5M | -$15.2M | |||
| Prepaid Expense And Other Assets Current | $642.0K | $454.0K | $649.0K | $577.0K | $531.0K | $337.0K | $879.0K | $793.0K | $432.0K | $418.0K | $868.0K | $580.0K | $778.0K | $944.0K | $1.4M | |||
| Liabilities And Stockholders Equity | $4.8M | $5.7M | $4.0M | $5.5M | $7.0M | $4.6M | $4.4M | $5.6M | $2.1M | $5.6M | $8.0M | $5.9M | $10.1M | $11.6M | $14.6M | |||
| Liabilities | $2.8M | $2.4M | $2.8M | $1.8M | $2.3M | $1.8M | $2.2M | $1.6M | $2.1M | $2.1M | $4.3M | $2.6M | $1.4M | $1.8M | $2.6M | |||
| Cash And Cash Equivalents At Carrying Value | $4.1M | $5.1M | $3.3M | $4.7M | $6.4M | $4.1M | $3.5M | $4.8M | $1.7M | $4.7M | $5.2M | $2.5M | $5.9M | $10.5M | $13.0M | |||
| Assets | $4.8M | $5.7M | $4.0M | $5.5M | $7.0M | $4.6M | $4.4M | $5.6M | $2.1M | $5.6M | $8.0M | $5.9M | $10.1M | $11.6M | $14.6M | |||
| Accrued Liabilities Current | $1.4M | $960.0K | $1.4M | $531.0K | $935.0K | $999.0K | $1.1M | $1.2M | $1.4M | $700.0K | $854.0K | $1.2M | $731.0K | $694.0K | $985.0K | |||
| Accounts Payable Current | $1.3M | $1.3M | $1.4M | $1.1M | $1.2M | $637.0K | $988.0K | $307.0K | $528.0K | $1.2M | $1.8M | $1.2M | $488.0K | $886.0K | $1.3M | |||
| Liabilities Current | $2.8M | $2.3M | $2.8M | $1.7M | $2.2M | $1.7M | $2.2M | $1.6M | $2.1M | $4.3M | $2.5M | $1.3M | $1.7M | $2.4M | ||||
| Common Stock Value Outstanding | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | ||||
| Assets Current | $4.7M | $5.6M | $3.9M | $5.3M | $6.9M | $4.4M | $4.4M | $5.6M | $5.6M | $7.8M | $5.8M | $9.9M | $11.4M | $14.3M | ||||
| Additional Paid In Capital Common Stock | $51.0M | $49.0M | $44.0M | $41.5M | $40.4M | $36.2M | $31.8M | $31.4M | $31.4M | $30.8M | $30.0M | $27.9M | $27.5M | $27.4M | ||||
| Change In Fair Value Of Warrant Liability | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K | $2.0K | $46.0K | $122.0K | $0.00 | $0.00 | $0.00 | |||||||
| Property Plant And Equipment Net | $1.0K | $2.0K | $3.0K | $5.0K | $6.0K | $7.0K | $9.0K | $9.0K | $0.00 | $0.00 | $1.0K | |||||||
| Operating Lease Right Of Use Asset | $84.0K | $97.0K | $109.0K | $131.0K | $141.0K | $152.0K | $28.0K | $41.0K | ||||||||||
| Operating Lease Liability Noncurrent | $30.0K | $44.0K | $58.0K | $84.0K | $96.0K | $109.0K | $0.00 | $0.00 | ||||||||||
| Operating Lease Liability Current | $54.0K | $52.0K | $50.0K | $47.0K | $45.0K | $43.0K | $28.0K | $41.0K | ||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $11.0K | $14.0K | $12.0K | |||||||||||||||
| Debt Discount And Additional Paid In Capital Recognized From Issuance Of Warrants | $0.00 | $532.0K | ||||||||||||||||
| Debt Conversion Converted Instrument Amount1 | $0.00 | $350.0K | ||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $124.0K | $124.0K | $124.0K | |||||||||||||||
| Finance Lease Right Of Use Asset Amortization | $0.00 | $19.0K | $18.0K | $18.0K | ||||||||||||||
| Finance Lease Principal Payments | $0.00 | $23.0K | $34.0K | $29.0K | ||||||||||||||
| Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | $247.0K | $97.0K | $45.0K | |||||||||||||||
| Stock Issued For Repayment Of Notes Payable | ||||||||||||||||||
| Net Liabilities Assumed In Connection With Reverse Recapitalization | ||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | -$16.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $793.0K | $148.0K | $388.0K | $25.0K | $626.0K | $154.0K |
| Net Cash Provided By Used In Operating Activities | -$10.2M | -$8.6M | -$9.0M | -$1.1M | -$8.3M | -$3.7M |
| Net Cash Provided By Used In Financing Activities | $13.4M | $11.8M | $10.8M | $1.0M | $15.7M | -$4.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$251.0K | -$313.0K | $547.0K | $35.0K | $55.0K | $464.0K |
| Increase Decrease In Accrued Liabilities | $59.0K | -$479.0K | $125.0K | $696.0K | $583.0K | $371.0K |
| Increase Decrease In Accounts Payable | $663.0K | -$387.0K | $2.2M | $897.0K | -$308.0K | $980.0K |
| Net Cash Provided By Used In Investing Activities | -$3.0K | $0.00 | -$8.0K | -$3.0K | -$3.8M | -$2.0K |
| Proceeds From Convertible Debt | $0.00 | $125.0K | $350.0K | $0.00 | ||
| Proceeds From Notes Payable | $0.00 | $1.3M | $1.3M | $0.00 | $61.0K | |
| Payments Of Stock Issuance Costs | $2.2M | $2.0M | $517.0K | $111.0K | ||
| Increase Decrease In Operating Lease Liability | -$48.0K | $105.0K | -$57.0K | -$43.0K | ||
| Payments To Acquire Property Plant And Equipment | $3.0K | $0.00 | $8.0K | $3.0K | $0.00 | $2.0K |
| Proceeds From Issuance Of Common Stock | $12.3M | $0.00 | ||||
| Proceeds From Advances From Employees | $0.00 | $190.0K | $35.0K | |||
| Payments Of Debt Issuance Costs | $0.00 | $150.0K | $13.0K | |||
| Proceeds From Warrant Exercises | $0.00 | $762.0K | $12.0K | $0.00 | ||
| Proceeds From Issuance Initial Public Offering | $3.4M | $15.1M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $220.0K | $37.0K | $13.0K | $181.0K | $168.0K | $35.0K |
| Net Cash Provided By Used In Operating Activities | -$1.7M | -$2.2M | -$579.0K | -$2.3M | -$2.9M | -$766.0K |
| Net Cash Provided By Used In Financing Activities | -$11.0K | $4.5M | $1.0M | -$23.0K | $15.8M | -$29.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$196.0K | -$564.0K | -$28.0K | -$39.0K | $793.0K | $87.0K |
| Increase Decrease In Accrued Liabilities | $562.0K | -$172.0K | -$36.0K | -$225.0K | $138.0K | $226.0K |
| Increase Decrease In Accounts Payable | $331.0K | -$744.0K | $408.0K | $315.0K | $121.0K | $200.0K |
| Net Cash Provided By Used In Investing Activities | $0.00 | $1.2M | $0.00 | -$2.0K | ||
| Proceeds From Convertible Debt | $0.00 | $350.0K | ||||
| Proceeds From Notes Payable | $0.00 | $1.3M | ||||
| Payments Of Stock Issuance Costs | $10.0K | $1.0M | $110.0K | |||
| Increase Decrease In Operating Lease Liability | -$11.0K | -$14.0K | -$16.0K | |||
| Payments To Acquire Property Plant And Equipment | $2.0K | |||||
| Proceeds From Issuance Of Common Stock | $5.5M | $0.00 | ||||
| Proceeds From Advances From Employees | $0.00 | $190.0K | ||||
| Payments Of Debt Issuance Costs | $0.00 | $105.0K | ||||
| Proceeds From Warrant Exercises | ||||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $15.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$121.80 | -$1.5K | -$5.0K | -$24.95 | -$1.42 | -$1.07 |
| Weighted Average Number Of Shares Outstanding Basic | 98.2K | 6.5K | 2.6K | 129.0K | 6.5M | 4.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 98.2K | 6.5K | 2.6K | 129.0K | 6.5M | 4.5M |
| Earnings Per Share Basic | $-121.80 | $-1,545.55 | $-5,018.09 | $-24.95 | $-1.42 | $-1.07 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 497.7K | 18.8K | 2.9K | 142.8K | 6.8M | 4.5M |
| Common Stock Shares Issued | 497.7K | 18.8K | 2.9K | 142.8K | 6.8M | 4.5M |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 1.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.28 | -$1.31 | -$5.80 | -$11.42 | -$61.85 | -$101.05 | -$65.78 | -$239.37 | -$15.04 | -$0.39 | -$0.35 | -$11.62 | -$0.18 | -$0.34 | -$0.46 | -$0.23 | -$0.25 | -$0.26 |
| Weighted Average Number Of Shares Outstanding Basic | 2.6M | 2.2M | 525.4K | 185.9K | 36.4K | 18.7K | 32.5K | 28.2K | 143.0K | 896.1K | 851.4K | 227.1K | 6.8M | 6.8M | 5.7M | 4.5M | 4.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 2.6M | 2.2M | 525.4K | 185.9K | 36.4K | 18.7K | 32.5K | 28.2K | 143.0K | 896.1K | 851.4K | 227.1K | 6.8M | 6.8M | 5.7M | 4.5M | 4.5M | |
| Earnings Per Share Basic | $-1.28 | $-1.31 | $-5.80 | $-11.42 | $-61.85 | $-101.05 | $-65.78 | $-239.37 | $-15.04 | $-0.39 | $-0.35 | $-11.62 | $-0.18 | $-0.34 | $-0.46 | $-0.23 | $-0.25 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 3.3M | 2.5M | 525.4K | 5.0M | 801.9K | 3.2M | 3.0M | 3.0M | 449.4K | 12.7M | 6.8M | 6.8M | 6.8M | 4.5M | 6.8M | |||
| Common Stock Shares Issued | 3.3M | 2.5M | 525.4K | 5.0M | 801.9K | 3.2M | 3.0M | 3.0M | 449.4K | 12.7M | 10.5M | 6.8M | 6.8M | 6.8M | 6.8M | |||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | |||
| Temporary Equity Shares Outstanding | 7.8K | 7.8K | 7.8K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $793.0K | $148.0K | $388.0K | $25.0K | $626.0K | $154.0K |
| Fair Value Adjustment Of Warrants | $0.00 | -$3.0K | -$182.0K | $0.00 | $0.00 | |
| Depreciation | $4.0K | $4.0K | $4.0K | $3.0K | ||
| Stock Issued During Period Value New Issues | $11.2M | $2.2M | $15.1M | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.9M | $532.0K | $399.0K | |||
| Gain Loss On Derivative Instruments Net Pretax | $0.00 | -$89.0K | $0.00 | |||
| Amortization Of Financing Costs And Discounts | $0.00 | $2.1M | $217.0K | |||
| Repayment Of Advances From Employees | $0.00 | $195.0K | $30.0K | |||
| Warrants Issued | $440.0K | $287.0K | $18.0K | $0.00 | ||
| Warrants And Rights Outstanding | $0.00 | |||||
| Stock Issued For Payment Of Reverse Recapitalization Costs | $0.00 | $1.9M | $0.00 | |||
| Payment Of Reverse Recapitalization Costs | $0.00 | $3.0M | $0.00 | |||
| Other Noncash Expense | $0.00 | $12.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $465.0K | $41.0K | $220.0K | $37.0K | $37.0K | $37.0K | $326.0K | $13.0K | $13.0K | -$136.0K | -$85.0K | $181.0K | $134.0K | $138.0K | $168.0K | $52.0K | $28.0K | $35.0K | |
| Fair Value Adjustment Of Warrants | $0.00 | -$2.0K | $0.00 | -$757.0K | $266.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Depreciation | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $1.0M | $4.1M | $4.4M | $2.2M | $15.1M | ||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $532.0K | $30.0K | $399.0K | ||||||||||||||||
| Gain Loss On Derivative Instruments Net Pretax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$89.0K | $0.00 | $0.00 | |||||||||||
| Amortization Of Financing Costs And Discounts | $0.00 | $1.2M | $1.2M | ||||||||||||||||
| Repayment Of Advances From Employees | $0.00 | $195.0K | |||||||||||||||||
| Warrants Issued | |||||||||||||||||||
| Warrants And Rights Outstanding | $18.0K | $63.0K | $185.0K | $0.00 | $225.0K | $1.6M | |||||||||||||
| Stock Issued For Payment Of Reverse Recapitalization Costs | |||||||||||||||||||
| Payment Of Reverse Recapitalization Costs | |||||||||||||||||||
| Other Noncash Expense | $0.00 | $10.0K |
Most recent annual filing with the SEC: January 30, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.